Search

Author/Creator Reboredo, M.

1. First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study. (September 2018)

Authors:
Aranda, E.; García-Alfonso, P.; Benavides, M.; Sánchez Ruiz, A.; Guillén-Ponce, C.; Safont, M.J.; Alcaide, J.; Gómez, A.; López, R.; Manzano, J.L.; Méndez Ureña, M.; Sastre, J.; Rivera, F.; Grávalos, C.; García, T.; Martín-Valadés, J.I.; Falcó, E.; Navalón, M.; González Flores, E.; M García Tapia...
Journal:
European journal of cancer
Issue:
Volume 101(2018)
Page Start:
263
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. First-line single-agent panitumumab in frail elderly patients with wild-type KRAS metastatic colorectal cancer and poor prognostic factors: A phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours. Issue 11 (July 2015)

Authors:
Sastre, J.; Massuti, B.; Pulido, G.; Guillén-Ponce, C.; Benavides, M.; Manzano, J.L.; Reboredo, M.; Rivera, F.; Grávalos, C.; Safont, M.J.; Martínez Villacampa, M.; Llovet, P.; Dotor, E.; Díaz-Rubio, E.; Aranda, E.; Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Journal:
European journal of cancer
Issue:
Volume 51:Issue 11(2015:Jul.)
Page Start:
1371
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search